01345.HK
Shanghai Pioneer Holding Ltd
HKSE · Healthcare · Medical - Pharmaceuticals · CN
HKD 2.16
−3.79%Year over year
Reported trailing growth
- Revenue
- -20.8%
- EBITDA
- -7.6%
- EBIT
- -18.5%
- EPS
- -34.7%
- Free cash flow
- +468.2%
- Operating cash flow
- +2612.6%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -6.2%
- EBITDA
- -11.1%
- EBIT
- -15.4%
- Net income
- -21.4%
- EPS
- -20.8%
- Free cash flow
- +114.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026